HOME OCT
DEAD

Serial Number

90265111

Owner

NotalVision, Inc.

Attorney

Manuel Valcarcel, Esq.

Filing Date

Oct 20, 2020

Add to watchlist:

No watchlists yet
View on USPTO

HOME OCT Trademark

Serial Number: 90265111

HOME OCT is a trademark filed by NotalVision, Inc. on October 20, 2020. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

NotalVision, Inc. (4 trademarks)

7717 COPPERMINE DRIVE
MANASSAS, VA 20109

Entity Type: 03

Notal Vision Inc. (19 trademarks)

Manassas, VA 20109

Entity Type: 03

Trademark Details

Filing Date

October 20, 2020

Registration Date

Not Registered

Goods & Services

Medical services, namely, vision care services and eye care services; provision of optical medical services, ophthalmic services, and ophthalmic diagnostic services; patient rehabilitation care services; medical consultations in the nature of provision of medical second opinions; information, advisory and consultancy services relating to all of the aforementioned services; providing information relating to opthalmic services and opthalmic diagnostic services; providing a website and online computer database featuring vision care and eye care, optical and ophthalmic medical information for use by medical and healthcare service providers and patients; providing patient-specific information to healthcare professionals

Medical devices, apparatus, instruments and equipment for the viewing, detection, diagnosis, management and treatment of retinal diseases, namely, macular degeneration, diabetic macular edema (DME), retinal vein occlusion(RVO), high Myopia and Glaucoma; medical devices, apparatus, instruments, and equipment for the viewing, detection, diagnosis, management and treatment of macular degeneration, diabetic macular edema (DME), retinal vein occlusion (RVO), high Myopia and Glaucoma and other eye conditions and diseases; optical coherence tomography devices and equipment for home use; medical devices, apparatus, instruments, and equipment for monitoring progression of eye conditions and diseases and in particular for use in the detection and characterization of patients with age-related macular degeneration, diabetic macular edema (DME), retinal vein occlusion (RVO), high Myopia and Glaucoma; and parts and fittings for all the aforementioned goods

Software as a service (SAAS) services, namely, hosting a cloud-based platform that allows for uploading and analyzing test results; Software as a service (SAAS) services featuring non-downloadable software and proprietary algorithms for analyzing optical coherence tomography imaging; Providing online, non-downloadable software allowing for interactive communications and exchange of information between healthcare professionals and patients; Providing online, non-downloadable software for healthcare professionals to receive and provide patient-specific information; Providing online, non-downloadable software for use by medical and healthcare service providers and patients in accessing an online computer database conveying information in the fields of vision care and eye care, optical and ophthalmic medical information; Providing a website featuring online, non-downloadable software for use by medical and healthcare service providers and patients in accessing an online computer database conveying information in the fields of vision care and eye care, optical and ophthalmic medical information

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 25, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
May 25, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 25, 2022 ABN2
ASSIGNED TO EXAMINER
Jan 3, 2022 DOCK
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 10, 2021 GNFN
FINAL REFUSAL E-MAILED
Nov 10, 2021 GNFR
FINAL REFUSAL WRITTEN
Nov 10, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 27, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 25, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 25, 2021 TROA
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 31, 2021 ASGN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 25, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 25, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 7, 2020 NWOS
NEW APPLICATION ENTERED
Oct 23, 2020 NWAP